Neogenomics (NEO) Deferred Taxes (2022 - 2026)

Neogenomics (NEO) has 5 years of Deferred Taxes data on file, last reported at $626000.0 in Q2 2026.

• Quarterly Deferred Taxes fell 36.96% year-over-year to $626000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $3.2 million (down 3.42% YoY) and the FY2025 annual result came in at $3.4 million, up 9.41% from the prior year.
• Deferred Taxes fell to $626000.0 in Q2 2026, from $769000.0 in the prior quarter.
• In the past five years, Deferred Taxes ranged from a high of $5.7 million in Q2 2022 to a low of -$869000.0 in Q3 2025.
• A 5-year average of $2.0 million and a median of $1.7 million in 2023 frame the typical range for Deferred Taxes.
• The widest YoY moves for Deferred Taxes: up 109.05% in 2025, down 456.15% in 2025.
• Tracing NEO's Deferred Taxes over 5 years: stood at $3.3 million in 2022, then tumbled by 45.34% to $1.8 million in 2023, then retreated by 14.18% to $1.6 million in 2024, then soared by 73.14% to $2.7 million in 2025, then tumbled by 76.76% to $626000.0 in 2026.
• The last three Deferred Taxes figures came in at $626000.0 (Q2 2026), $769000.0 (Q1 2026), and $2.7 million (Q4 2025), per Business Quant data.